Optimapharm

Optimapharm is a globally operating, leading, mid-sized, full-service CRO focused on our people, consistent quality delivery to our clients, and supporting the development of new therapies to improve and save patients’ lives. The company provides successful tailor-made clinical research solutions to Biotech, Pharma, and Medical Device companies.

With 26 strategically located offices, Optimapharm is giving unrivalled access to Patients and Investigators worldwide. Optimapharm conducts phase I – IV studies in all therapeutic areas, specifically focusing on Oncology/Haemato-oncology, Cardio-metabolic, CNS, Respiratory, GI&GU, Immunology/Rheumatology, and complex medical device studies. With very strong operational teams, Optimapharm has a reputation for excellent delivery in all projects, including rescue studies.
  
Optimapharm - We Deliver on Your Promises
Web site: https://optimapharm.eu

Contact

Danilo Stancetic
Business Development Director
Phone: +36 30 407 6336
E-Mail: danilo.stancetic@optimapharm.eu